Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Microbiol
Päätekijät: Kim, Jiyeon, Lee, Heetae, An, Jinho, Song, Youngcheon, Lee, Chong-Kil, Kim, Kyungjae, Kong, Hyunseok
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Microbiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736992/
https://ncbi.nlm.nih.gov/pubmed/31551944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01947
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia